Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
US7498129B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 13, 2006 |
| Grant date | Mar 3, 2009 |
| Priority date | — |
| Expiry date | Oct 3, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to cell surface antigens found on myeloma cells and on ovarian cancer cells, and monoclonal antibodies, and antibody binding fragments thereof, capable of being used for therapeutic, diagnostic, detection and cell purification purposes. An exemplified monoclonal antibody of the present invention recognizes and binds to an epitope common to surface antigen expressed on multiple myeloma cells and on ovarian cancer cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.